JingZhouHouMD

Oncology • Pittsburgh, PA

Physician

Join to view full profile

Dr. Hou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hou's full profile

Already have an account?

Office
5115 Centre Ave FL 3
The Hillman Cancer Center
Pittsburgh, PA 15232
Phone+1 412-235-1020

Fax+1 412-235-1030

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology, 2003 - 2006
Canton Medical Education Foundation/NEOMEDResidency, Internal Medicine, 2000 - 2003
Henan Medicine UniversityClass of 1986

Certifications & Licensure

CA State Medical License 2003 - Present
PA State Medical License 2006 - 2024
OH State Medical License 2000 - 2003

Clinical Trials

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects Start of enrollment: 2021 Sep 13
Recruiting
Phase 1
Roles: Contact

Publications & Presentations

PubMed

395 citations
Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Andrew H. Wei, Pau Montesinos, VV Ivanov, Courtney D. DiNardo, Jan Novák
Blood. 2020-06-11
450 citations
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.
Andrew H. Wei, Stephen A. Strickland, Jing Zhou Hou, Walter Fiedler, Tara L. Lin
Journal of Clinical Oncology. 2019-03-20
320 citations
Differential impact of mammalian target of rapamycin inhibition on CD4 + CD25 + Foxp3 + regulatory T cells compared with conventional CD4 + T cells
Robert Zeiser, Dennis B. Leveson-Gower, Elizabeth A. Zambricki, Neeraja Kambham, Andreas Beilhack
Blood. 2008-01-01

Press Mentions

Cells Are More Resilient to Environmental Changes Than Previously ThoughtMay 13th, 2021